Patch testing in non-immediate drug eruptions

Allergy, Asthma and Clinical Immunology

Volumn 4, Issue 2, 2008, Pages 66-74

  Romano, Antonino ^a,b,c   Viola, Marinella ^a   Gaeta, Francesco ^a   Rumi, Gabriele ^a   Maggioletti, Michela ^a  

^a CATHOLIC UNIVERSITY   (Italy)

^b OASI RESEARCH INSTITUTE IRCCS   (Italy)

^c Unita di Allergologia   (Italy)

Author keywords

Delayed reading intradermal tests; Non immediate reactions; Patch tests

Indexed keywords

ACICLOVIR; AMOXICILLIN; AMPICILLIN; ANTIBIOTIC AGENT; ANTICONVULSIVE AGENT; BETA LACTAM ANTIBIOTIC; CARBAMAZEPINE; CELECOXIB; CEPHALOSPORIN DERIVATIVE; CIPROFLOXACIN; CLINDAMYCIN; CORTICOSTEROID; COTRIMOXAZOLE; ERYTHROMYCIN; GANCICLOVIR; GENTAMICIN; GLUCOCORTICOID; HEPARIN DERIVATIVE; IODINATED CONTRAST MEDIUM; ISONIAZID; NORFLOXACIN; OFLOXACIN; PENICILLIN DERIVATIVE; PENICILLIN G; PENICILLOYL POLYLYSINE; PRISTINAMYCIN; STEROID HORMONE; SULFONAMIDE; TETRACYCLINE; UNINDEXED DRUG;

ALGORITHM; ANGIONEUROTIC EDEMA; ARTICLE; DELAYED HYPERSENSITIVITY; DIAGNOSTIC TEST; DRUG ERUPTION; HUMAN; INTRACUTANEOUS TEST; LYMPHOCYTE TRANSFORMATION TEST; MACULOPAPULAR RASH; PATCH TEST; PROVOCATION TEST; PUSTULOSIS; RASH; SENSITIVITY AND SPECIFICITY; STEVENS JOHNSON SYNDROME; TOXIC EPIDERMAL NECROLYSIS; URTICARIA;

EID: 45849122534     PISSN: 17101484     EISSN: None     Source Type: Journal    
DOI: 10.2310/7480.2008.00009     Document Type: Article

References (48)

1. Romano A, Quaratino D, Di Fonso M, et al. A diagnostic protocol for evaluating nonimmediate reactions to aminopenicillins. J Allergy Clin Immunol 1999;103:1186-90.
2. Bocquet H, Bagot M, Roujeau J-C. Drug-induced pseudolymphoma and drug hypersensitivity syndrome (drug rash with eosinophilia and systemic symptoms-DRESS). Semin Cutan Med Surg 1996;15:250-7.
3. Pichler WJ. Delayed drug hypersensitivity reactions. Ann Intern Med 2003;139:683-93.
4. Posadas S, Pichler WJ. Delayed drug hypersensitivity reactions - new concepts. Clin Exp Allergy 2007;37:989-99.
5. Romano A, Torres MJ, Quaratino D, et al. Diagnostic evaluations of delayed hypersensitivity to systemically administered drugs. Allergy 1999;54 Suppl 58:23-7.
6. Barbaud A, Gonçalo M, Bruynzeel D, Bircher A. Guidelines for performing skin tests with drugs in the investigation of cutaneous adverse drug reactions. Contact Dermatitis 2001;45:321-8.
7. Brockow K, Romano A, Blanca M, et al. General considerations for skin test procedures in the diagnosis of drug hypersensitivity. Allergy 2002;57:45-51.
8. Romano A, Blanca M, Torres MJ, et al. Diagnosis of nonimmediate reactions to β-lactam antibiotics. Allergy 2004;59:1153-60.
9. Phillips EJ, Wong GA, Kaul R, et al. Clinical and immunogenetic correlates of abacavir hypersensitivity. AIDS 2005;19:979-81.
10. Dooms-Goossens A, Verschaeve H, Degreef H, van Berendrocks J. Contact allergy to hydrocortisone and tixocortol pivalate: problems in detection of corticosteroid sensitivity. Contact Dermatitis 1986; 14:94-102.
11. Rosso R, Mattiacci G, Bernardi ML, et al. Very delayed reactions to β-lactam antibiotics. Contact Dermatitis 2000;42:293-5.
12. Gonçalo M, Oliveira HS, Monteiro C, et al. Allergic and systemic contact dermatitis from estradiol. Contact Dermatitis 1999;40:58-9.
13. Aberer W, Bircher A, Romano A, et al. Drug provocation testing in the diagnosis of drug hypersensitivity reactions: general considerations. Allergy 2003;58:854-63.
14. Romano A, Viola M, Mondino C, et al. Diagnosing nonimmediate reactions to penicillins by in vivo tests. Int Arch Allergy Immunol 2002;129:169-74.
15. Aihara M, Ikezawa Z. Evaluation of the skin test reactions with delayed type rash induced by penicillins and cephalosporins. J Dermatol 1987;14:440-8.
16. Terrados S, Blanca M, Garcia J, et al. Nonimmediate reactions to betalactams: prevalence and role of the different penicillins. Allergy 1995;50:563-7.
17. Luque I, Leyva L, Torres MJ, et al. In vitro T-cell responses to β-lactam drugs in immediate and nonimmediate allergic reactions. Allergy 2001;56:611-8.
18. Lammintausta K, Kortekangas-Savolainen O. The usefulness of skin tests to prove drug hypersensitivity. Br J Dermatol 2005;152: 968-74.
19. López Serrano C, Vilas F, Cabañas R, Contreras J. Delayed hypersensitivity to β-lactams. J Invest Allergol Clin Immunol 1994; 4:315-9.
20. Alanko K. Topical provocation of fixed drug eruption. A study of 30 patients. Contact Dermatitis 1994;31:25-7.
21. Lee AY. Topical provocation in 31 cases of fixed drug eruption: change of causative drugs in 10 years. Contact Dermatitis 1998;38: 258-60.
22. Schmid DA, Depta JP, Pichler WJ. T cell-mediated hypersensitivity to quinolones. Clin Exp Allergy 2006;36:59-69.
23. Romano A, Pettinato R, Andriolo M, et al. Hypersensitivity to aromatic anticonvulsants: in vivo and in vitro cross-reactivity studies. Curr Pharm Des 2006;12:3373-81.
24. Motley RJ, Reynolds AJ. Carbamazepine and patch testing [letter]. Contact Dermatitis 1989;21:285-6.
25. Osawa J, Naito S, Aihara M, et al. Evaluation of skin test reactions in patients with non-immediate type drug eruptions. J Dermatol 1990;17:235-9.
26. Prens EP, Troost RJJ, van Parys JAP, et al. The value of the lymphocyte proliferation assay in detection of carbamazepine allergy. Contact Dermatitis 1990;23:292.
27. Alanko K. Patch testing in cutaneous reactions caused by carbamazepine. Contact Dermatitis 1993;29:254-7.
28. Troost RJJ, van Parys JAP, Hooijkaas H, et al. Allergy to carbamazepine: parallel in vivo and in vitro detection. Epilepsia 1996;37:1093-9.
29. Lee AY, Choi J, Chey WY. Patch testing with carbamazepine and its main metabolite carbamazepine epoxide in cutaneous adverse drug reactions to carbamazepine. Contact Dermatitis 2003;48:137-9.
30. Vaillant L, Camenen I, Lorette G. Patch testing with carbamazepine: reinduction of an exfoliative dermatitis [letter]. Arch Dermatol 1989;125:299.
31. Wütschert R, Piletta P, Bounameaux H. Adverse skin reactions to low molecular weight heparins. Drug Saf 1999;20:515-25.
32. Koch P, Münssinger T, Rupp-John C, Uhl K. Delayed-type hypersensitivity skin reactions caused by subcutaneous unfractioned and low-molecular weight heparins: tolerance of a new recombinant hirudins. J Am Acad Dermatol 2000;42:612-9.
33. Bircher AJ, Harr T, Hohenstein L, Tsakiris DA. Hypersensitivity reactions to anticoagulant drugs. Allergy 2006;61:1432-40.
34. Christiansen C. Late-onset allergy-like reactions to x-ray contrast media. Curr Opin Allergy Clin Immunol 2002;2:333-9.
35. Brockow K, Christiansen C, Kanny G, et al. Management of hypersensitivity reactions to iodinated contrast media. Allergy 2005;60:150-8.
36. Guéant-Rodriguez RM, Romano A, Barbaud A, et al. Hypersensitivity reactions to iodinated contrast media. Curr Pharm Des 2006;12:3359-72.
37. Vernassiere C, Trechot P, Commun N, et al. Low negative predictive value of skin tests in investigating delayed reactions to radio-contrast media. Contact Dermatitis 2004;50:359-66.
38. Dooms-Goossens A, Morren M. Results of routine patch tests with corticosteroid series in 2073 patients. Contact Dermatitis 1992;26: 182-91.
39. Matura M, Goossens A. Contact allergy to corticosteroids. Allergy 2000;55:698-704.
40. Whitmore SE. Delayed systemic allergic reactions to corticosteroids. Contact Dermatitis 1995;32:193-8.
41. Ventura MT, Calogiuri GF, Muratore L, et al. Cross-reactivity in cell-mediated and IgE-mediated hypersensitivity to glucocorticoids. Curr Pharm Des 2006;12:3383-91.
42. Padial A, Posadas S, Torres MJ, et al. Nonimmediate reactions to systemic corticosteroids suggest an immunological mechanism. Allergy 2005;60:665-70.
43. Isaksson M, Bruze M, Goossens A, Lepoittevin JP. Patch testing with budesonide in serial dilutions: the significance of dose, occlusion time and reading time. Contact Dermatitis 1999;40:24-31.
44. Wilkinson SM, Beck HM. Corticosteroid contact hypersensitivity: what vehicle and concentration? Contact Dermatitis 1996;34:305-8.
45. Dooms-Goossens A. Corticosteroid contact allergy: a challenge to patch testing. Am J Contact Dermatitis 1993;4:120-6.
46. Herbst RA, Lauerma AI, Maibach HI. Intradermal testing in the diagnosis of allergic contact dermatitis: a reappraisal. Contact Dermatitis 1993;29:1-5.
47. Barbaud A, Reichert-Penetrat S, Tréchot P, et al. The use of skin testing in the investigation of cutaneous adverse drug reactions. Br J Dermatol 1998;139:49-58.
48. Wolkenstein P, Chosidow O, Fléchet M-L, et al. Patch testing in severe cutaneous adverse drug reactions, including Stevens-Johnson syndrome and toxic epidermal necrolysis. Contact Dermatitis 1996;35:234-6.